StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock.
Titan Pharmaceuticals Stock Performance
Titan Pharmaceuticals stock opened at $10.00 on Wednesday. The stock’s 50-day moving average is $5.89 and its 200-day moving average is $6.62. Titan Pharmaceuticals has a 12 month low of $4.24 and a 12 month high of $14.80.
About Titan Pharmaceuticals
See Also
- Five stocks we like better than Titan Pharmaceuticals
- How is Compound Interest Calculated?
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- What Do S&P 500 Stocks Tell Investors About the Market?
- Lowe’s Stock: Hold Now, Buy it When it Dips
- Insider Buying Explained: What Investors Need to Know
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.